Enhanced NLCs: Elevating therapeutic and diagnostic performance through covalent dye integration

Nanostructured lipid carriers (NLCs) are widely investigated as versatile drug delivery systems. In this study, we aimed to design, synthesize, and characterize a novel fluorescently labeled NLC platform incorporating a rhodamine B–oleic acid conjugate (Rd-OA) as a proof-of-concept model for future therapeutic applications. NLCs were prepared using Precirol® ATO 5, oleic acid and Rd-OA, and Tween® 20 (T20) or Tween® 80 (T80). The resulting nanoparticles exhibited sizes of 350–500 nm, narrow polydispersity indices (<0.2), and highly negative zeta potentials (∼–30 mV), confirming stable colloidal properties. Rd-OA was efficiently integrated (100% incorporation efficiency) with different concentrations. Molecular dynamics simulations provided atomic-level structural insights, revealing surfactant-dependent differences in component organization consistent with experimental data. NLCs were stable over a period of three months. In vitro assays in keratinocytes cells demonstrated a concentration-dependent cytotoxicity effect influenced by Rd-OA content, while fluorescence microscopy confirmed efficient cellular internalization of the NLCs. Collectively, these findings support the developed fluorescent NLC system as a stable, reproducible, and traceable platform suitable for future adaptation in drug delivery and imaging applications.” • Developed a novel nanostructured lipid carrier (NLC) system covalently linked to a fluorescent dye for combined drug delivery and bioimaging. • Demonstrated enhanced nanoparticle stability, supported by in silico modeling predictions and experimental validation. • Achieved reliable real-time tracking and precise localization through covalent dye integration, minimizing dye leakage and false signals. • Validated the biocompatibility of the NLC system, ensuring safety for biomedical applications. • Presented a versatile, multifunctional nanocarrier platform with strong potential for clinical translation in theranostics and precision medicine.

Authors

Institutions

Publication Details

Journal
Journal of Drug Delivery Science and Technology
Published
2025-10-04
DOI
https://doi.org/10.1016/j.jddst.2025.107612
Citations
1
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhanced NLCs: Elevating therapeutic and diagnostic performance through covalent dye integration

Sónia L. C. Pinho, Javier Morales, Osvaldo Yáñez, Gabriela Urra et al.
1 citations
Journal of Drug Delivery Science and Technology
Advanced Drug Delivery Systems
0.79
article

Enhanced NLCs: Elevating therapeutic and diagnostic performance through covalent dye integration

Sónia L. C. Pinho, Javier Morales, Osvaldo Yáñez, Gabriela Urra, Daniel A. Bustos, Joana Borga
article en
1 citations

Abstract

Nanostructured lipid carriers (NLCs) are widely investigated as versatile drug delivery systems. In this study, we aimed to design, synthesize, and characterize a novel fluorescently labeled NLC platform incorporating a rhodamine B–oleic acid conjugate (Rd-OA) as a proof-of-concept model for future therapeutic applications. NLCs were prepared using Precirol® ATO 5, oleic acid and Rd-OA, and Tween® 20 (T20) or Tween® 80 (T80). The resulting nanoparticles exhibited sizes of 350–500 nm, narrow polydispersity indices (<0.2), and highly negative zeta potentials (∼–30 mV), confirming stable colloidal properties. Rd-OA was efficiently integrated (100% incorporation efficiency) with different concentrations. Molecular dynamics simulations provided atomic-level structural insights, revealing surfactant-dependent differences in component organization consistent with experimental data. NLCs were stable over a period of three months. In vitro assays in keratinocytes cells demonstrated a concentration-dependent cytotoxicity effect influenced by Rd-OA content, while fluorescence microscopy confirmed efficient cellular internalization of the NLCs. Collectively, these findings support the developed fluorescent NLC system as a stable, reproducible, and traceable platform suitable for future adaptation in drug delivery and imaging applications.” • Developed a novel nanostructured lipid carrier (NLC) system covalently linked to a fluorescent dye for combined drug delivery and bioimaging. • Demonstrated enhanced nanoparticle stability, supported by in silico modeling predictions and experimental validation. • Achieved reliable real-time tracking and precise localization through covalent dye integration, minimizing dye leakage and false signals. • Validated the biocompatibility of the NLC system, ensuring safety for biomedical applications. • Presented a versatile, multifunctional nanocarrier platform with strong potential for clinical translation in theranostics and precision medicine.

Journal of Drug Delivery Science and TechnologyVol. 114
Catholic University of the Maule (CL), Polytechnic Institute of Coimbra (PT), Center of New Drugs for Hypertension (CL), Escola Universitária Vasco da Gama (PT), University of the Americas (CL), Advanced Center for Chronic Diseases (CL), University of Chile (CL), University of Coimbra (PT)
Openalex Percentile: Top 23%
Advanced Drug Delivery Systems
0.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.